Evidence map›Paper›PMID 29615433›Full record

ArticleCancer research2018

Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases.

Willemijne A M E Schrijver, Pier Selenica, Ju Youn Lee, Charlotte K Y Ng, Kathleen A Burke, Salvatore Piscuoglio, Samuel H Berman, Jorge S Reis-Filho, Britta Weigelt, Paul J van Diest and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell Carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  13. Onco-Breastomics: An Eco-Evo-Devo Holistic Approach.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Beyond Genetics: Metastasis as an Adaptive Response in Breast Cancer.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Willemijne A M E SchrijverDepartment of Pathology, University Medical Center Utrecht, the Netherlands.
Pier SelenicaDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Ju Youn LeeDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Charlotte K Y NgDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-6100-0026
Kathleen A BurkeDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Salvatore PiscuoglioDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Samuel H BermanDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Jorge S Reis-FilhoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Britta WeigeltDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. p.j.vandiest@umcutrecht.nl weigeltb@mskcc.org.
Paul J van DiestDepartment of Pathology, University Medical Center Utrecht, the Netherlands. p.j.vandiest@umcutrecht.nl weigeltb@mskcc.org.
Cathy B MoelansDepartment of Pathology, University Medical Center Utrecht, the Netherlands.
Memorial Sloan Kettering Cancer Center · USUtrecht University · NL

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Although the repertoire of somatic genetic alterations of primary breast cancers has been extensively catalogued, the genetic differences between primary and metastatic tumors have been less studied. In this study, we compared somatic mutations and gene copy number alterations of primary breast cancers and their matched metastases from patients with estrogen receptor (ER)-negative disease. DNA samples obtained from formalin-fixed paraffin-embedded ER-negative/HER2-positive (

Indexed as

AdultBiomarkers, TumorBrain NeoplasmsDatasets as TopicDisease-Free SurvivalDNA Copy Number VariationsDNA Mutational AnalysisErb-b2 Receptor Tyrosine KinasesFemaleGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansKaplan-Meier EstimateMiddle AgedMutationReceptors, EstrogenBiomarkers, TumorERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesReceptors, Estrogen

Identifiers

PMID29615433
PMCPMC6355142
OpenAlexW2795724091

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.